Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bacterial Protein Maturation

Bacterial Protein Maturation

Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...

Covalently Linked Protein Regulators

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cyclopropyl-1,1-Dinitrile as a Five-Atom Synthon: Regioselective Ring-Opening and a Keteneimine-Enamine-Based Nitrile-to-Nitrile Condensation Affording an Entry to Pyridines.

The Journal of organic chemistry·2026

Same author

Nanotherapeutic strategies for mitigating sepsis-induced multiorgan dysfunctions.

Nanomedicine (London, England)·2026

Same author

Preparation of goat milk-based herbal <i>kalakand</i> enriched with rhododendron flower juice and jaggery: sensory and functional characterization.

Journal of food science and technology·2026

Same author

Biosynthetically natural product-conserved scaffolds: Harnessing power with molecular-medicinal strategy for new therapeutic development.

Bioorganic & medicinal chemistry letters·2026

Same author

Translocation of bacteria from the gut to the brain in mice.

PLoS biology·2026

Same author

Coupling programmable shape morphing and solvent-fueled propulsion in a soft bicontinuous composite.

Nature communications·2026

Search research articles

Related Experiment Video

Updated: Jul 14, 2025

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

Published on: June 28, 2013

Development of QTMP: A promising anticancer agent through NP-Privileged Motif-Driven structural modulation.

Pritam Giri¹, Pooja J Batra², Anuradha Kumari²

¹Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, SAS Nagar, Mohali, Punjab 160062, India.

Bioorganic & Medicinal Chemistry

|October 10, 2023

Summary

Researchers developed a novel anticancer agent, QTMP, by modifying Combretastatin. QTMP effectively inhibits cancer cell proliferation and tubulin assembly, showing significant potential against various cancer types.

Keywords:

Anticancer Clinical trial agent-inspired Colchicine-binding site Drug-likeness G2/M arrest NP-privileged motif Natural product-inspired Tubulin polymerization inhibition

More Related Videos

Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction

Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction

Published on: October 6, 2022

A Novel Saturation Mutagenesis Approach: Single Step Characterization of Regulatory Protein Binding Sites in RNA Using Phosphorothioates

A Novel Saturation Mutagenesis Approach: Single Step Characterization of Regulatory Protein Binding Sites in RNA Using Phosphorothioates

Published on: August 21, 2018

Related Experiment Videos

Last Updated: Jul 14, 2025

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

Published on: June 28, 2013

Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction

Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction

Published on: October 6, 2022

A Novel Saturation Mutagenesis Approach: Single Step Characterization of Regulatory Protein Binding Sites in RNA Using Phosphorothioates

A Novel Saturation Mutagenesis Approach: Single Step Characterization of Regulatory Protein Binding Sites in RNA Using Phosphorothioates

Published on: August 21, 2018

Area of Science:

Medicinal Chemistry
Molecular Biology
Pharmacology

Background:

Combretastatin A-4 (CA-4) is a potent anti-cancer agent that targets tubulin.
Developing novel analogs with improved properties and broader efficacy is crucial for cancer therapy.

Purpose of the Study:

To synthesize and evaluate novel Combretastatin analogs with enhanced anti-cancer properties.
To investigate the mechanism of action and drug-like characteristics of the most potent compounds.

Main Methods:

Structural modulation of Combretastatin using privileged motifs.
Synthesis of trimethoxyphenyl-2-aminoimidazole derivatives with quinoline and isoquinoline scaffolds.
In vitro antiproliferative assays against various cancer cell lines.
Tubulin polymerization and depolymerization assays.
Cell cycle analysis.
Binding studies to the colchicine site on tubulin.
In silico drug-likeness assessment.

Main Results:

A series of novel compounds were synthesized, featuring unsymmetric aryl substitutions.
Compounds 6, 11, and 13 exhibited potent inhibition of HeLa cell proliferation (10-46 nM).
Compound 6 (QTMP) demonstrated superior antiproliferative activity compared to CA-4 across multiple cancer cell lines.
QTMP inhibited tubulin assembly, depolymerized microtubules, induced spindle defects, and caused G2/M phase arrest.
QTMP binds to the colchicine site on tubulin and possesses enhanced aqueous stability and favorable in silico drug-like properties.

Conclusions:

QTMP is a promising anti-cancer agent with potent antiproliferative activity.
Its mechanism involves disruption of microtubule dynamics.
QTMP exhibits favorable drug-like properties and stability, suggesting its potential for further development as a cancer therapeutic.